Key result
Oral salsalate fails to improve ACh-induced vasodilation or macrovascular function in Non-Hispanic Black women.
Why the study?
Does oral salsalate improve micro- and macrovascular function in Non-Hispanic Black women?
RCT (n=13)
Does oral salsalate improve micro- and macrovascular function in Non-Hispanic Black women?
p-value: p=0.24
Short-term salsalate treatment marginally improved cutaneous microvascular, but not macrovascular, function in Non-Hispanic Black women, suggesting a role for NF-κB-mediated inflammation in microvascular dysfunction.
No overall vascular benefit with salsalate; leaves open NF-κB role in site-specific microvascular responses.
Non-Hispanic Black (NHB) adults demonstrate impaired microvascular endothelial function, characterized as reduced nitric oxide (NO)-mediated vasodilation, compared to non-Hispanic White adults. A sexual dimorphism exists, where microvascular dysfunction in NHB men is mediated through elevated superoxide generation in NHB men, but not NHB women. Inflammatory mechanisms in NHB women may contribute, but these mechanisms have not been explored in vivo. We hypothesized that micro- and macrovascular function would improve following oral salsalate [nuclear factor kappa B (NF-κB) activation inhibitor] in NHB women. Following placebo or salsalate (1500 mg, b.i.d., 5 days), two intradermal microdialysis fibers were placed in 13 NHB women [28 (7) years]. Local heating units (33 °C) and laser-Doppler flowmetry (flux) probes were placed over each fiber. Increasing concentrations of acetylcholine were perfused alone (ACh; dissolved in lactated Ringer’s) or with N G -nitro-L-arginine methyl ester (ACh+L-NAME). Cutaneous vascular conductance was calculated (CVC=flux*mmHg -1 ) and normalized to site-specific maximum (28 mM sodium nitroprusside + 43 °C). Macrovascular endothelial function was assessed using brachial artery flow-mediated dilation (FMD) and handgrip-augmented FMD (FMD+HG). Salsalate treatment did not impact ACh-induced vasodilation overall (main effect, p=0.24), but a treatment*site interaction effect emerged (p < 0.0001). ACh increased and ACh+L-NAME decreased following salsalate (both p ≤ 0.03), but this effect was small (Cohen’s f=0.19). Five-day salsalate treatment did not alter %FMD (p=0.28) or %FMD+HG (p=0.17). Cutaneous microvascular, but not macrovascular, function marginally improved following salsalate, indicating inflammation via NF-κB pathways contributes to impaired cutaneous microvascular function in NHB women.
No takes yet. Share an insight, caveat, or question.
Content et al. (2026) conducted an RCT in Impaired microvascular endothelial function (n=13). Salsalate vs. Placebo was evaluated on ACh-induced vasodilation overall (p=0.24). Oral salsalate (1500 mg twice daily for 5 days) did not significantly improve overall ACh-induced vasodilation (p=0.24) or macrovascular function (p=0.28) in Non-Hispanic Black women.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: